A low-intensity peak can be scientifically important, but visibility alone does not make it trustworthy. It may represent a genuine metabolite or reflect interference, contamination, carryover, unstable chromatography or processing choices. Confidence comes from an evidence chain showing that the feature belongs to the sample, is reproducible and supports the intended conclusion.¹

Confidence develops as the candidate survives a series of tests across the analytical workflow. Sample preparation must preserve it, chromatography must separate it from relevant interferences, acquisition must capture sufficient precursor and product-ion evidence and controls must distinguish it from background. When evidence converges across these stages, a weak signal can support a defensible decision on detection, identification or quantitation.

Detection, identification and quantitation answer different questions

Define the Decision the Evidence Must Support

A weak signal can be sufficient for discovery without being strong enough for structural identification or quantitation. Define the matrix, expected range, biological contrast and intended use, then set criteria that prevent a detectable feature from being carried forward with more certainty than the data support.

Preserve Low-Abundance Metabolites Through Sample Preparation

A metabolite lost or altered during collection and preparation cannot be recovered through more sensitive acquisition. Collection timing, stabilization, storage, extraction recovery and contamination determine whether it reaches the instrument in a representative form.

Balance coverage and cleanliness. Test recovery and stability in the relevant matrix. Broad extraction may increase coverage but add matrix components; selective cleanup can reduce background and ion suppression but lose analytes. Use blanks to trace contamination and suitable internal standards to monitor preparation, injection and matrix effects, recognizing that unmatched standards may not reflect every analyte.²

Confirm Reproducible Retention and Resolution From Interferences

A preserved analyte can still disappear within poor retention, a broad peak or coelution. Confidence depends on reproducible retention, adequate separation and a defined peak, not signal intensity alone.

Match the separation to the analyte and matrix. Select reversed-phase, HILIC or another mode based on polarity, retention, sample load and background because column choice can change feature coverage.³ Balance LC flow rate, sensitivity, robustness and sample consumption,⁴ then confirm resolution from neighboring peaks and isomers, retention-time precision, carryover and performance in the relevant matrix.

Collect Sufficient Precursor and Product-Ion Evidence

A well-resolved peak may remain inconclusive if acquisition collects too few ions or too little structural information. Obtain interpretable precursor and product-ion evidence while retaining enough data points across the chromatographic peak.

Balance acquisition trade-offs. Longer accumulation may improve spectral quality but reduce peak sampling; faster scans or higher thresholds may increase coverage or quality while missing weak candidates. Optimize collision conditions and use targeted reacquisition when fragmentation is insufficient.

Distinguish the Feature From Background and Carryover

Structural evidence is insufficient if the feature cannot be distinguished from background or carryover. Blanks, pooled QC samples and system suitability samples help assess background, reproducibility and system performance.^1,5

Review the sequence, not just the sample. Compare samples with relevant blanks, check carryover after high-concentration injections and trace recurring background to solvents, consumables, preparation or the LC-MS system. Retain a feature also found in blanks only when its sample response consistently exceeds a predefined, justified threshold.

Evaluate Feature Credibility Through Transparent Processing and Raw-Data Review

Once the sequence supports a sample-derived feature, processing must show that its strength and reproducibility are not artifacts. Peak picking, smoothing, integration, alignment, gap filling and blank subtraction can recover weak patterns but also amplify noise.

Verify the raw data. Use transparent, versioned settings and confirm that the feature persists under reasonable parameter changes. Review traces, spectra, blanks, peak boundaries and replicates; treat features dependent on aggressive processing with caution.¹ Scalable workflows can help teams detect, annotate and prioritize candidates, but expert review remains essential.

Support Metabolite Identity with Independent Evidence

A reproducible signal establishes presence, not identity. Multiple compounds, isomers, adducts or in-source fragments may fit a precursor mass, so independent evidence must converge on the same assignment.

Build confidence from converging evidence:

• Accurate mass and isotope pattern
• Retention behavior
• MS/MS fragments and library comparison
• Expected biotransformation or pathway context
• An authentic standard when the required identification level calls for it⁶

When the evidence does not converge, retain the uncertainty rather than forcing a single assignment.

Demonstrate Reproducibility and Clearly Report Uncertainty

A plausible assignment is more useful when the feature is consistently detected across relevant samples and controls. Replicates, pooled QC samples, detection frequency, precision, batch behavior and stability show whether the evidence persists under conditions that matter to the decision.

Match validation to the goal. Quantitative work requires fit-for-purpose calibration, selectivity, accuracy, precision, stability and range; exploratory work still needs defined criteria. Treat values below the lower limit of quantitation as more uncertain than those within the calibrated range.

Report detection, quantitation and identification status explicitly rather than treating confidence as a single scale. Align these illustrative labels with your organization’s adopted identification framework:

Detection and quantitation status

• Non-detect: No qualifying signal
• Detected, not quantified: Signal present without a validated concentration

Identification confidence

• Tentative annotation: Candidate assignment with unresolved uncertainty
• Probable identity: Multiple lines of evidence support the assignment, but confirmation is incomplete
• Confirmed identity: An authentic standard matches under defined conditions

Diagnose the Dominant Source of Uncertainty

When confidence remains low, use the failure pattern to identify the weakest link in the evidence chain before changing the entire method.

Improve the Evidence Chain, Not Only the Signal

Confidence in a low-abundance metabolite comes from converging evidence, not signal intensity alone. Strengthening the least certain part of the workflow helps teams distinguish a promising feature from a result that is reproducible, explainable and fit for the intended decision.

Explore workflow guidance and resources for strengthening evidence across metabolite detection, identification and quantitative monitoring.

References

1. González-Domínguez A, et al. QC omics: recommendations and guidelines for robust, easily implementable and reportable quality control of metabolomics data. Anal Chem. 2024;96(3):1064-1072. doi:10.1021/acs.analchem.3c03660.
2. Zhu P, et al. Development of an untargeted LC-MS metabolomics method with postcolumn infusion for matrix effect monitoring in plasma and feces. J Am Soc Mass Spectrom. 2024;35(3):590-602. doi:10.1021/jasms.3c00418.
3. Hemmer S, et al. Comparison of reversed-phase, hydrophilic interaction, and porous graphitic carbon chromatography columns for an untargeted toxicometabolomics study. Metabolomics. 2024;20:49. doi:10.1007/s11306-024-02115-0.
4. Harwood-Stamper AJ, Rowland CA, Dunn WB. Development of microflow ultra-high-performance liquid chromatography-mass spectrometry metabolomic assays for analysis of mammalian biofluids. Metabolomics. 2024;20:120. doi:10.1007/s11306-024-02187-y.
5. Ramos M, Camel V, Le Roux E, Farah S, Cladiere M. Effect of different pooled QC samples on data quality during an inter-batch experiment in untargeted UHPLC-HRMS analysis on two different MS platforms. Anal Bioanal Chem. 2025;417(2):311-321. doi:10.1007/s00216-024-05646-6.
6. Metz TO, Chang CH, Gautam V, et al. Introducing identification probability for automated and transferable assessment of metabolite identification confidence in metabolomics and related studies. Anal Chem. 2025;97(1):1-11. doi:10.1021/acs.analchem.4c04060.